Course: Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France
CME Credits: 1.00
Released: 2021-12-20
COVID-19 mRNA vaccine immunogenicity and effectiveness are well established in adolescents. However, the effect of vaccination on multisystem inflammatory syndrome in children (MIS-C), a severe complication associated with SARS-CoV-2, has not yet been described. Summer 2021 in France was marked by both a fourth wave of COVID-19 cases due to the Delta variant, with a peak in August 2021, and by the recommendation of the French Public Health Agency to vaccinate children aged 12 years or older. We estimated the risk of MIS-C among adolescents by COVID-19 vaccination status during September 2021 and October 2021.
Educational Objective
To identify the key insights or developments described in this article
View Full Course